Windsor Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Hold
2,549
0.45% 33
2025
Q4
$524K Sell
2,549
-570
-18% -$107K 0.47% 32
2025
Q3
$490K Hold
3,119
0.43% 37
2025
Q2
$524K Hold
3,119
0.74% 24
2025
Q1
$430K Hold
3,119
0.56% 27
2024
Q4
$369K Hold
3,119
0.43% 37
2024
Q3
$345K Sell
3,119
-116
-4% -$12.1K 0.39% 44
2024
Q2
$318K Buy
3,235
+45
+1% +$4.58K 0.64% 27
2024
Q1
$357K Buy
3,190
+67
+2% +$7.23K 1.01% 24
2023
Q4
$315K Hold
3,123
0.94% 30
2023
Q3
$271K Hold
3,123
0.64% 35
2023
Q2
$295K Hold
3,123
0.73% 30
2023
Q1
$236K Hold
3,123
0.56% 39
2022
Q4
$240K Buy
+3,123
New +$237K 0.64% 40

Other funds holding CAH

Windsor Advisory Group's CAH Position: Q1 2026 in Review

Windsor Advisory Group held its Cardinal Health (CAH) position steady in Q1 2026 at 2,549 shares worth $539K. The position accounts for 0.45% of the portfolio, ranked #33.

Windsor Advisory Group first reported a position in CAH in Q4 2022 and has held it in 14 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Windsor Advisory Group held 2,549 shares of Cardinal Health worth $539K as of Q1 2026.
  • Windsor Advisory Group left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 0.45% of Windsor Advisory Group's portfolio in Q1 2026, its #33 holding.
  • Windsor Advisory Group first reported a position in Cardinal Health in Q4 2022 and has held it in 14 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Windsor Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.